A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
Clinical trials in Lafayette, LA: what is studied
Cancer. The Cancer Center of Acadiana and local urology practices take part in cancer studies, including prostate cancer and bladder cancer; see our oncology clinical trials page.
Digestive diseases. The Gastroenterology Clinic of Acadiana takes part in studies for Crohn's disease, ulcerative colitis, and other digestive conditions.
Vaccines and healthy volunteers. Vaccine studies recruit in Lafayette, and some local studies accept healthy volunteers. If you have never taken part in research, our guide explains how to volunteer for clinical trials.
Other conditions. Studies in heart disease, asthma, COPD, wound care, and weight loss also recruit in the area.
Paid clinical trials in Lafayette and Acadiana
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. Payments are reviewed by the institutional review board that oversees the study, and under FDA guidance they are usually paid out over the course of the study rather than only at the end. Many studies at least cover travel, which helps if you are coming from elsewhere in Acadiana.
Our guide explains how much clinical trials pay and how payment is decided.
Clinical trials in New Iberia, Eunice, and across Acadiana
Some studies recruit at research sites in smaller Acadiana towns such as New Iberia and Eunice, and studies at those sites appear on this page alongside those in Lafayette. For larger hospital programs, see our Baton Rouge page, about an hour east, and our New Orleans page, or browse all Louisiana clinical trials.
How to join a clinical trial in Lafayette
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as Crohn's disease or prostate cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Lafayette or a nearby town such as New Iberia or Eunice.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Can I leave a clinical trial after I join?
Yes. Participation is voluntary, and you can leave a study at any time without affecting your regular medical care. The study team may ask you to come for a final safety visit. Our guide explains informed consent and your rights as a participant.